NeuroOne Medical Technologies Corporation — Income Charts
3 years of history · ending 2025-09-30 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$9M
Cost of Revenue
$4M
Gross Profit
$5M
R&D
$5M
SG&A
$7M
D&A
$262K
Operating Income
$-4M
EBITDA
$-4M
Interest Expense
—
Other Income/Expense
$621K
Pretax Income
$-4M
Tax Provision
—
Net Income
$-4M
Gross Margin
56.5%
Operating Margin
-46.5%
Net Margin
-39.6%
Effective Tax Rate
—
Deferred Tax Assets
$19M
Deferred Tax Liabilities
—
DTA Valuation Allowance
$20M
Tax Credit Carryforwards
$2M
NOL Carryforwards
$49M
ETR (Continuing Operations)
—
ETR Federal Statutory
21.0%
ETR State + Local (pp)
7.7%
ETR Foreign Differential (pp)
—
Operating Lease Cost
—
Revenue YoY Variation
—
Income YoY Variation
—